New York State Common Retirement Fund’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-32
| Closed | -$272 | – | 3190 |
|
|
2024
Q2 | $272 | Sell |
32
-1,555
| -98% | -$23.4K | ﹤0.01% | 3366 |
|
|
2024
Q1 | $27.5K | Buy |
1,587
+5
| +0.3% | +$89 | ﹤0.01% | 3110 |
|
|
2023
Q4 | $20.3K | Sell |
1,582
-5
| -0.3% | -$117 | ﹤0.01% | 3155 |
|
|
2023
Q3 | $58.7K | Buy |
1,587
+12
| +0.8% | +$534 | ﹤0.01% | 2968 |
|
|
2023
Q2 | $63.4K | Sell |
1,575
-9
| -0.6% | -$509 | ﹤0.01% | 3082 |
|
|
2023
Q1 | $115K | Sell |
1,584
-780
| -33% | -$75.7K | ﹤0.01% | 2781 |
|
|
2022
Q4 | $194K | Sell |
2,364
-3
| -0.1% | -$313 | ﹤0.01% | 2736 |
|
|
2022
Q3 | $224K | Buy |
2,367
+10
| +0.4% | +$1.12K | ﹤0.01% | 2729 |
|
|
2022
Q2 | $459K | Sell |
2,357
-221
| -9% | -$36.1K | ﹤0.01% | 2396 |
|
|
2022
Q1 | $599K | Buy |
2,578
+267
| +12% | +$85K | ﹤0.01% | 2335 |
|
|
2021
Q4 | $911K | Sell |
2,311
-8
| -0.3% | -$3.37K | ﹤0.01% | 2144 |
|
|
2021
Q3 | $1.04M | Sell |
2,319
-520
| -18% | -$186K | ﹤0.01% | 2094 |
|
|
2021
Q2 | $1.1M | Buy |
2,839
+27
| +1% | +$9.63K | ﹤0.01% | 2179 |
|
|
2021
Q1 | $1.01M | Hold |
2,812
| – | – | ﹤0.01% | 2132 |
|
|
2020
Q4 | $1.38M | Buy |
2,812
+708
| +34% | +$327K | ﹤0.01% | 1882 |
|
|
2020
Q3 | $682K | Hold |
2,104
| – | – | ﹤0.01% | 2066 |
|
|
2020
Q2 | $766K | Buy |
2,104
+152
| +8% | +$38.4K | ﹤0.01% | 2008 |
|
|
2020
Q1 | $415K | Hold |
1,952
| – | – | ﹤0.01% | 2132 |
|
|
2019
Q4 | $804K | Hold |
1,952
| – | – | ﹤0.01% | 2063 |
|
|
2019
Q3 | $689K | Buy |
1,952
+200
| +11% | +$74.6K | ﹤0.01% | 2177 |
|
|
2019
Q2 | $881K | Hold |
1,752
| – | – | ﹤0.01% | 2084 |
|
|
2019
Q1 | $1.74M | Buy |
1,752
+104
| +6% | +$96.6K | ﹤0.01% | 1682 |
|
|
2018
Q4 | $1.43M | Sell |
1,648
-264
| -14% | -$245K | ﹤0.01% | 1716 |
|
|
2018
Q3 | $1.98M | Buy |
1,912
+104
| +6% | +$102K | ﹤0.01% | 1689 |
|
|
2018
Q2 | $1.66M | Buy |
1,808
+380
| +27% | +$408K | ﹤0.01% | 1802 |
|
|
2018
Q1 | $1.39M | Buy |
1,428
+228
| +19% | +$208K | ﹤0.01% | 1830 |
|
|
2017
Q4 | $543K | Buy |
1,200
+212
| +21% | +$78.3K | ﹤0.01% | 2318 |
|
|
2017
Q3 | $409K | Hold |
988
| – | – | ﹤0.01% | 2451 |
|
|
2017
Q2 | $346K | Hold |
988
| – | – | ﹤0.01% | 2597 |
|
|
2017
Q1 | $508K | Hold |
988
| – | – | ﹤0.01% | 2375 |
|
|
2016
Q4 | $351K | Hold |
988
| – | – | ﹤0.01% | 2533 |
|
|
2016
Q3 | $528K | Buy |
988
+104
| +12% | +$56.5K | ﹤0.01% | 2292 |
|
|
2016
Q2 | $497K | Buy |
884
+160
| +22% | +$76.8K | ﹤0.01% | 2281 |
|
|
2016
Q1 | $344K | Hold |
724
| – | – | ﹤0.01% | 2425 |
|
|
2015
Q4 | $478K | Buy |
724
+96
| +15% | +$72.6K | ﹤0.01% | 2349 |
|
|
2015
Q3 | $494K | Buy |
628
+145
| +30% | +$177K | ﹤0.01% | 2324 |
|
|
2015
Q2 | $637K | Buy |
+483
| New | +$554K | ﹤0.01% | 2412 |
|
Other funds holding ATRA
EC
RG
VPC
TCM
